Better efficacy of intrapleural infusion of bevacizumab with pemetrexed for malignant pleural effusion mediated from nonsquamous non-small cell lung cancer

BACKGROUND AND OBJECTIVE: Several clinical trials have reported that intrapleural infusion of bevacizumab with or without cisplatin exhibits encouraging efficacy in nonsquamous non-small cell lung cancer (NS-NSCLC) patients with malignant serous cavity effusion. However, most of the studies included...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Xinyu, Chen, Dawei, Guo, Jun, Kong, Li, Wang, Haiyong, Wang, Zhehai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267356/
https://www.ncbi.nlm.nih.gov/pubmed/30568464
http://dx.doi.org/10.2147/OTT.S184030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267356/
https://www.ncbi.nlm.nih.gov/pubmed/30568464
http://dx.doi.org/10.2147/OTT.S184030

Ejemplares similares